• Hitachi Chemical
    Hitachi Chemical has recently obtained the license for Accelltas latest media which is devoid of human/animal derived components and comprised only of artificially synthesized substances, offering a high level of safety that is key to the success of regenerative medicine.
    http://www.hitachi-chem.co.jp
    Hitachi Chemical


    STEMCELL Technologies
    Accellta granted exclusive worldwide rights for micro-carrier free stem cells suspension culture to STEMCELL Technologies.
    http://www.stemcell.com/


    Ajinomoto Co.
    Accellta has granted worldwide non-exclusive rights to Ajinomoto Co. Inc. for manufacturing and distribution of proprietary cell culture medium and ancillary products and methods.
    http://www.ajinomoto.com/en/


    EMD Millipore
    Accellta has granted worldwide non-exclusive rights to EMD Millipore for manufacturing and distribution of proprietary cell culture medium and ancillary products and methods.
    http://www.emdmillipore.com/